Market Closed -
NSE India S.E.
07:43:48 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
194
INR
|
+1.07%
|
|
+6.30%
|
-13.43%
|
Fiscal Period: March |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Capitalization
1 |
1,449
|
1,348
|
984.9
|
821.5
|
1,277
|
1,716
|
Enterprise Value (EV)
1 |
1,588
|
1,134
|
860.8
|
661.2
|
1,073
|
1,724
|
P/E ratio
|
17.7
x
|
32.8
x
|
31
x
|
6.58
x
|
9.38
x
|
24.1
x
|
Yield
|
1.84%
|
1.32%
|
0.9%
|
3.24%
|
2.09%
|
1.04%
|
Capitalization / Revenue
|
0.39
x
|
0.39
x
|
0.24
x
|
0.18
x
|
0.23
x
|
0.23
x
|
EV / Revenue
|
0.42
x
|
0.33
x
|
0.21
x
|
0.15
x
|
0.19
x
|
0.23
x
|
EV / EBITDA
|
8.64
x
|
10.7
x
|
12.6
x
|
3.52
x
|
5.19
x
|
11.3
x
|
EV / FCF
|
-13.2
x
|
3.13
x
|
-9.15
x
|
-410
x
|
19.3
x
|
-8.93
x
|
FCF Yield
|
-7.58%
|
32%
|
-10.9%
|
-0.24%
|
5.19%
|
-11.2%
|
Price to Book
|
0.86
x
|
0.78
x
|
0.57
x
|
0.46
x
|
0.65
x
|
0.84
x
|
Nbr of stocks (in thousands)
|
8,881
|
8,881
|
8,881
|
8,881
|
8,881
|
8,881
|
Reference price
2 |
163.2
|
151.8
|
110.9
|
92.50
|
143.8
|
193.2
|
Announcement Date
|
9/2/17
|
9/4/18
|
8/26/19
|
6/25/20
|
8/18/21
|
5/26/23
|
Fiscal Period: Maart |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net sales
1 |
3,758
|
3,415
|
4,024
|
4,462
|
5,654
|
7,536
|
EBITDA
1 |
183.8
|
105.9
|
68.47
|
188
|
206.6
|
152.1
|
EBIT
1 |
113.3
|
42.69
|
14.04
|
131.6
|
153.3
|
86.58
|
Operating Margin
|
3.02%
|
1.25%
|
0.35%
|
2.95%
|
2.71%
|
1.15%
|
Earnings before Tax (EBT)
1 |
101.9
|
49.49
|
12.61
|
176.5
|
154.3
|
95.78
|
Net income
1 |
82.08
|
41.05
|
31.74
|
124.9
|
136.1
|
71.27
|
Net margin
|
2.18%
|
1.2%
|
0.79%
|
2.8%
|
2.41%
|
0.95%
|
EPS
2 |
9.242
|
4.622
|
3.574
|
14.07
|
15.32
|
8.025
|
Free Cash Flow
1 |
-120.4
|
362.3
|
-94.12
|
-1.612
|
55.75
|
-193
|
FCF margin
|
-3.2%
|
10.61%
|
-2.34%
|
-0.04%
|
0.99%
|
-2.56%
|
FCF Conversion (EBITDA)
|
-
|
342.09%
|
-
|
-
|
26.98%
|
-
|
FCF Conversion (Net income)
|
-
|
882.63%
|
-
|
-
|
40.96%
|
-
|
Dividend per Share
2 |
3.000
|
2.000
|
1.000
|
3.000
|
3.000
|
2.000
|
Announcement Date
|
9/2/17
|
9/4/18
|
8/26/19
|
6/25/20
|
8/18/21
|
5/26/23
|
Fiscal Period: March |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
139
|
-
|
-
|
-
|
-
|
7.96
|
Net Cash position
1 |
-
|
215
|
124
|
160
|
203
|
-
|
Leverage (Debt/EBITDA)
|
0.755
x
|
-
|
-
|
-
|
-
|
0.0523
x
|
Free Cash Flow
1 |
-120
|
362
|
-94.1
|
-1.61
|
55.8
|
-193
|
ROE (net income / shareholders' equity)
|
5.02%
|
2.41%
|
1.84%
|
7.05%
|
7.23%
|
3.57%
|
ROA (Net income/ Total Assets)
|
3.09%
|
1.15%
|
0.41%
|
3.64%
|
3.89%
|
2.12%
|
Assets
1 |
2,655
|
3,558
|
7,673
|
3,435
|
3,497
|
3,356
|
Book Value Per Share
2 |
189.0
|
194.0
|
196.0
|
203.0
|
221.0
|
229.0
|
Cash Flow per Share
2 |
16.30
|
20.30
|
19.90
|
27.30
|
9.410
|
4.000
|
Capex
1 |
49.6
|
8.19
|
34.1
|
52.5
|
75.7
|
21.9
|
Capex / Sales
|
1.32%
|
0.24%
|
0.85%
|
1.18%
|
1.34%
|
0.29%
|
Announcement Date
|
9/2/17
|
9/4/18
|
8/26/19
|
6/25/20
|
8/18/21
|
5/26/23
|
|
1st Jan change
|
Capi.
|
---|
| -13.43% | 20.65M | | +5.14% | 103B | | -5.63% | 63.04B | | +39.52% | 39.06B | | +12.91% | 37.58B | | +7.41% | 33.26B | | +6.85% | 19.22B | | +12.86% | 16.83B | | +7.73% | 15.03B | | +16.93% | 14.96B |
Other Commodity Chemicals
|